Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

This week, Mainz Biomed announced its newest Brand Ambassador, Petra Smeltzer Starke, known serving as General Counsel to the White House Council of Economic Advisors and Senior Advisor to ...

TELUS Digital Experience (TELUS Digital) officially launched its global rebrand today, transitioning from TELUS International to TELUS Digital. The new name reflects the company's commitment to ...

The overall response rate was significantly higher for Keytruda plus chemotherapy versus chemotherapy alone (52% versus 29%). The approval marks first indication for Keytruda in MPM in the US ...

The ambassador, Mojtaba Amini, lost an eye, according to two members of Iran’s Revolutionary Guards Corps who were briefed on the attack. By Farnaz Fassihi Iran’s ambassador to Lebanon ...

Merck & Co., Inc. MRK announced that the FDA had approved its blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), for a new indication. The regulatory body has now approved Keytruda in ...

Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...

(RTTNews) - Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy KEYTRUDA (pembrolizumab), in combination with ...